Kdi Capital Partners buys $27,527,864 stake in McKesson Corporation (MCK)

McKesson Corporation (MCK) : Kdi Capital Partners scooped up 83 additional shares in McKesson Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 12, 2016. The investment management firm now holds a total of 140,995 shares of McKesson Corporation which is valued at $27,527,864.McKesson Corporation makes up approximately 8.49% of Kdi Capital Partners’s portfolio.

Other Hedge Funds, Including , Bronfman E.l. Rothschild reduced its stake in MCK by selling 708 shares or 14.57% in the most recent quarter. The Hedge Fund company now holds 4,151 shares of MCK which is valued at $810,441. McKesson Corporation makes up approx 0.13% of Bronfman E.l. Rothschild’s portfolio.Tredje Ap-fonden reduced its stake in MCK by selling 129 shares or 0.59% in the most recent quarter. The Hedge Fund company now holds 21,858 shares of MCK which is valued at $4,267,556. McKesson Corporation makes up approx 0.18% of Tredje Ap-fonden’s portfolio.Calvert Investment Management reduced its stake in MCK by selling 37,748 shares or 37.46% in the most recent quarter. The Hedge Fund company now holds 63,033 shares of MCK which is valued at $12,270,004. McKesson Corporation makes up approx 0.61% of Calvert Investment Management’s portfolio.Diversified Trust Co boosted its stake in MCK in the latest quarter, The investment management firm added 12,320 additional shares and now holds a total of 14,197 shares of McKesson Corporation which is valued at $2,795,673. McKesson Corporation makes up approx 0.38% of Diversified Trust Co’s portfolio.Peddock Capital Advisors boosted its stake in MCK in the latest quarter, The investment management firm added 47 additional shares and now holds a total of 7,892 shares of McKesson Corporation which is valued at $1,560,248. McKesson Corporation makes up approx 0.98% of Peddock Capital Advisors’s portfolio.

McKesson Corporation opened for trading at $183.16 and hit $184.33 on the upside on Monday, eventually ending the session at $183.9, with a gain of 0.61% or 1.11 points. The heightened volatility saw the trading volume jump to 11,78,858 shares. Company has a market cap of $41,507 M.

On the company’s financial health, McKesson Corporation reported $3.50 EPS for the quarter, beating the analyst consensus estimate by $ 0.16 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $3.34. The company had revenue of $49733.00 million for the quarter, compared to analysts expectations of $50333.03 million. The company’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.14 EPS.

Investors should note that on Jul 26, 2016, McKesson Corporation announced a cash dividend of $0.2800. The company’s management has announced Aug 30, 2016 as the ex-dividend date and fixed the record date on Sep 1, 2016. The payable date has been fixed on Oct 3, 2016.

Many Wall Street Analysts have commented on McKesson Corporation. Company shares were Reiterated by Mizuho on Aug 11, 2016 to “Neutral”, Firm has raised the Price Target to $ 197 from a previous price target of $174 .Company shares were Reiterated by Mizuho on Jun 7, 2016 to “Neutral”, Firm has raised the Price Target to $ 174 from a previous price target of $164 .McKesson Corporation was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers and practice management technology clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical patient care financial supply chain and strategic management software solutions as well as connectivity outsourcing and other services including remote hosting and managed services to healthcare organizations.

Leave a Reply

McKesson Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on McKesson Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.